Alzheimer's Disease

A new study presenting the first data from a long-running US government trial is suggesting high levels of amyloid proteins in the brains of cognitively normal older adults can be an effective presymptomatic sign of early stage Alzheimer’s disease.

New research is suggesting high levels of a certain blood-based biomarker may serve as an early warning sign of Alzheimer’s disease, two years before symptoms develop. The preliminary study has yet to be verified in larger cohorts of patients.

Researchers behind a new study involving almost 20,000 patients has uncovered no evidence that asprin provides a therapeutic benefit when it comes to staving off cognitive impairment associated with Alzheimer's and other forms of dementia.

A trio of studies are investigating the role our brain’s immune cells play in the progression of Alzheimer’s disease. Researchers are revealing these cells can contribute to neurodegeneration, and how they may be harnessed to prevent neuron damage.

A new imaging study has found neuroinflammation may be more common in neurodegenerative diseases than previously suspected. The Cambridge research revealed brain inflammation to be a common thread across three different types of dementia.

A link between diseases such as Alzheimer’s and sleep loss has been frequently cited, and a new study has now discovered a signaling pathway that both regulates sleep and controls the protein aggregations commonly associated with neurodegeneration.

If you like spicy foods, then you're probably aware of the claimed anti-inflammatory qualities of turmeric. Scientists have now developed what they say is a more effective way of biologically delivering turmeric's active compound, curcumin.

Some exciting advances are being made when it comes to blood-testing for Alzheimer's, with the latest example offering a way to spot a traditionally hard-to-detect protein called tau, which is considered a key biomarker of the disease.

Scientists looking into bilingualism's effects on Alzheimer's have uncovered some new insights, finding that while knowing a second language can delay the onset of the disease, it can also significantly accelerate cognitive deterioration thereafter.

Inflammation can get out of hand, causing pain and contributing to diseases like Alzheimer’s and diabetes. A molecular “switch” in mice that could effectively turn off that reaction, possibly reversing these conditions and maybe even aging itself.

Researchers from the University of Wisconsin have published a new study describing a relationship between regular aerobic exercise and improved cognitive function, leading to a reduced vulnerability to Alzheimer’s among high-risk adults.

Scientists from McGill University are suggesting a novel microdose formulation of lithium could not only slow the progression of Alzheimer’s disease in its initial stages but potentially improve cognition at the early stages of decline.